Advertisement
Advertisement
TOPIC

National Medical Products Administration (China)

National Medical Products Administration (China)
The latest news and top stories on National Medical Products Administration. A prominent Beijing, China-based governmental regulatory agency, the National Medical Products Administration (NMPA) is dedicated to safeguarding public health by regulating drugs, medical devices, and cosmetics. Its primary mission involves ensuring the safety and efficacy of these products through comprehensive approval, registration, and post-market supervision. The NMPA’s main areas of activity include setting standards, conducting inspections, and managing adverse event monitoring.
China’s private sector

China’s drug firms set to compete on the world stage, analysts say

Amid systemic efficiency and a wave of innovation, the country’s biotech sector is expanding at a pace that has caught the market off guard.

‘Historic breakthrough’: China approves novel drug ahead of US, Japan and Europe

‘Systemic leap’: China’s drug innovation push yields bumper crop

videocam

Lab monkey prices soar as China’s biotech boom fuels windfall for breeders

In the first six months to June 30, there were 81 cross-border deals for innovative medicines worth a combined record of US$110 billion.

Advertisement
Advertisement
Advertisement
Help preserve 120 years of quality journalism.
SUPPORT NOW
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement